Wyeth Manufacturing Capacity Serves As Lure For Biotech Deals, Essner Says

Wyeth's manufacturing capacity makes it an attractive partner for biotech products, Wyeth CEO Robert Essner said at Morgan Stanley's Pharmaceutical CEOs Unplugged conference in New York City